RxDoctor Payments Data

Geoffrey Bowers, MD

Obstetrics & Gynecology · Voorhees, NJNPI 1740496991

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $161,788 of the $227,746 with a category attached, or 71.0%. Acessa Health Inc. accounts for 60.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $98,563 and has fallen 84.4% since, to $15,337 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$227,746in general payments, 2019–2025

Across 266 payments — averaging $856.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acessa Health Inc.$137K
  • Intuitive Surgical$47K
  • Meditrina$35K
  • Hologic Sales And Service, LLC$7K
  • Pacira Pharmaceuticals Incorporated$633
  • Caldera Medical, Inc$333
  • plus $1K from 21 others

What the payments were for

  • Consulting fees$161,78871%
  • Speaking & faculty fees$4,0002%
  • Travel & lodging$23,71310%
  • Food & beverage$5,8343%
  • Education$32,34114%
  • Gifts$720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$227,746 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$17,293
Medicare patients
34
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremproEstrogen,con/M-Progest Acet13$3,020
Estradiol15$987

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPrempro$249$3,02013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

Other obstetrics & gynecology in Voorhees

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →